14 insiders reported 97 Form 4 transactions for Tarsus Pharmaceuticals, Inc. (TARS) over the past 18 months (most recent 2026-09-17). Recent activity: YARNO WENDY L (Director) Buy 302 shares, PYOTT DAVID E I (Director) Buy 201 shares, LINK WILLIAM J PHD (Director) Buy 201 shares, LINK WILLIAM J PHD (Director) Sell 11,675 shares, LINK WILLIAM J PHD (Director) Sell 759 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-17 | YARNO WENDY L | Director | Buy | 302 | $0 |
| 2026-09-17 | PYOTT DAVID E I | Director | Buy | 201 | $0 |
| 2026-09-17 | LINK WILLIAM J PHD | Director | Buy | 201 | $0 |
| 2026-09-17 | LINK WILLIAM J PHD | Director | Sell | 11,675 | $914,503 |
| 2026-09-17 | LINK WILLIAM J PHD | Director | Sell | 759 | $59,961 |
| 2026-09-17 | LINK WILLIAM J PHD | Director | Sell | 66 | $5,281 |
| 2026-09-09 | Lin Elizabeth Yeu | Chief Medical Officer | Sell | 1,590 | $143,100 |
| 2026-09-09 | Azamian Bobak R. | President/CEO and Board Chair | Sell | 7,100 | $640,917 |
| 2026-09-09 | Lin Elizabeth Yeu | Chief Medical Officer | Sell | 5,387 | $457,895 |
| 2026-09-09 | Azamian Bobak R. | President/CEO and Board Chair | Sell | 2,900 | $264,683 |
| 2026-09-09 | Lin Elizabeth Yeu | Chief Medical Officer | Sell | 5,386 | $484,740 |
| 2026-09-09 | Lin Elizabeth Yeu | Chief Medical Officer | Sell | 1,590 | $135,150 |
| 2026-09-09 | Neervannan Seshadri | Chief Operating Officer | Sell | 4,564 | $387,940 |
| 2026-09-03 | Azamian Bobak R. | President/CEO and Board Chair | Sell | 10,000 | $800,600 |
| 2026-09-03 | Lin Elizabeth Yeu | Chief Medical Officer | Sell | 5,387 | $430,960 |
| 2026-09-03 | Lin Elizabeth Yeu | Chief Medical Officer | Sell | 1,590 | $127,200 |
| 2026-09-03 | Lin Elizabeth Yeu | Chief Medical Officer | Sell | 4,601 | $339,830 |
| 2026-06-22 | Azamian Bobak R. | President/CEO and Board Chair | Sell | 4,582 | $280,602 |
| 2026-06-22 | Azamian Bobak R. | President/CEO and Board Chair | Sell | 5,418 | $334,887 |
| 2026-06-17 | LINK WILLIAM J PHD | Director | Sell | 10,572 | $655,147 |
| 2026-06-17 | LINK WILLIAM J PHD | Director | Sell | 1,928 | $121,348 |
| 2026-06-17 | Goodrich Katherine | Director | Sell | 2,954 | $183,384 |
| 2026-06-17 | Farrow Jeffrey S | Chief Financial Officer and Chief Strategy Officer | Buy | 27,881 | $0 |
| 2026-06-17 | Farrow Jeffrey S | Chief Financial Officer and Chief Strategy Officer | Sell | 14,396 | $877,436 |
| 2026-06-16 | LINK WILLIAM J PHD | Director | Buy | 2,954 | $0 |
Source: SEC Form 4 filings · as of 2026-09-17